Health
Azithromycin with QT-prolonging drugs may elevate CV event risk – Healio
According to findings published in JAMA Network Open, the combination of azithromycin and QT-prolonging drugs was associated with a 40% increase in cardiac events compared with amoxicillin and QT-prolonging drugs.
However, in a large cohort, there was no diff…
According to findings published in JAMA Network Open, the combination of azithromycin and QT-prolonging drugs was associated with a 40% increase in cardiac events compared with amoxicillin and QT-prolonging drugs.
However, in a large cohort, there was no difference between use of azithromycin and amoxicillin in risk for CV events, researchers reported.
Source: Adobe Stock.
“In this large cohort study including more than 4 million episodes of both azithromycin and amoxicillin use, we found no …
-
General13 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business23 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business20 hours agoHere’s what analysts expect for the BHP share price in the coming year